Ultimately if BETonMACE succeeds (and I do like the chances very much) and then they succeed in proving Apabetalone works on other diseases like Kidney, Alzheimers, Thrombosis...etc etc etc. At that point I don't think $10 billion USD would be unrealistic.

But right now, with BETonMACE at about the 1 year mark, with a recent positive reccomendation from the Safety Data Monitoring Thinga Majiggie.....

At this point I think $5 is more than reasonable....and I think the only reason we're trading for less than $3 right now is because there are players who've decided to put RVX "on sale" in the hopes that that there are retail holders who will get scared.....That unlike shoppers seeing Maxwell house coffee on sale for $2 a jar and loading up....that we'll be scared and return those jars we paid more for.

I'm gonna keep putting more jars in my cart.